Munar Pharma

Munar Pharma ROE

Delisted

The Return on Equity (ROE) of Munar Pharma (MUN.WA) as of Nov 20, 2026 is -10.85 %. In the previous year, Return on Equity (ROE) was 267.47 % — a change of -104.06% (lower).

ROE

-10.85 %

YoY

-104.06%

Last updated:

In 2024, Munar Pharma's return on equity (ROE) was -10.85 %, a -104.06% increase from the 267.47 % ROE in the previous year.

The Munar Pharma ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2017
-4.81 PLN
Jan 1, 2018
-580.53 PLN
Jan 1, 2019
0.75 PLN
Jan 1, 2020
-123.70 PLN
Jan 1, 2021
-42.23 PLN
Jan 1, 2022
-13.75 PLN
Jan 1, 2023
267.47 PLN
Jan 1, 2024
-10.85 PLN
The Munar Pharma ROE history
YEARROEYoY
-10.85 %-104.06%
267.47 %-2,045.29%
-13.75 %-67.44%
-42.23 %-65.86%
-123.70 %-16,554.50%
0.75 %-100.13%
-580.53 %+11,958.02%
-4.81 %+32.17%
-3.64 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Munar Pharma Stock analysis

What does Munar Pharma do? No Gravity Games SA generates revenue by providing internet-related services, including content management systems, web shops, and website implementation. The company leverages its own technical infrastructure and programming resources to create and maintain specialized websites for its corporate clients. These digital assets include audiostereo.pl for audio enthusiasts, zagraj.com.pl as an online games portal, and legalneinfo.pl, which serves as an online catalogue of free software. The firm further supports application development and external software development for its corporate clients. Its portfolio extends to sport1.pl, offering information on disciplines such as football, volleyball, basketball, tennis, handball, and winter sports. Additional sites managed by the company include YOYO.pl, an independent provider of free hosting services, as well as chillisport.pl, oboe.pl, legenhit.pl, webtips.pl, xt.pl, and websonda.pl. Munar Pharma is one of the most popular companies on Eulerpool.

ROE Details

Decoding Munar Pharma's Return on Equity (ROE)

Munar Pharma's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Munar Pharma's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Munar Pharma's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Munar Pharma’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Munar Pharma stock

Return on Equity (ROE) of Munar Pharma is -10.85 % in 2024.

Return on Equity (ROE) of Munar Pharma changed from 267.47 % to -10.85 %, representing a -104.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Munar Pharma since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Munar Pharma with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Munar Pharma

All Key Metrics — Munar Pharma